Lichen planus

Journal of the American Academy of Dermatology

Volumn 25, Issue 4, 1991, Pages 593-619

  Boyd, Alan S ^a   Neldner, Kenneth H ^a  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AROTINOID; AZATHIOPRINE; BETAMETHASONE VALERATE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DAPSONE; ETRETINATE; GRISEOFULVIN; HYDROCORTISONE; ISOTRETINOIN; PREDNISONE; RETINOIC ACID; RETINOID; TEMAROTENE; TRIAMCINOLONE ACETONIDE;

ARTICLE; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; HUMAN; IMMUNOLOGY; LICHEN PLANUS; LICHENOID ERUPTION; MALIGNANT TRANSFORMATION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PUVA; TOPICAL DRUG ADMINISTRATION;

EID: 0026040662     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/0190-9622(91)70241-S     Document Type: Article

References (317)

1. On leichen planus
2. Lichen ruber pemphigoides
3. Sur un signe pathognomonique de Lichen du Wilson (lichen plan) stries et ponctuations grisatres
4. The pathogenesis of lichen planus
5. Syphilis and skin disease in the American Negro
6. Penicillin treatment of lichen ruber
7. Frequency, duration and localization of lichen planus
8. Lichen planus
9. Lichen planus: a statistical study of forty-one cases
10. Lichen planus: a theory of pathogenesis
11. Cancer development in oral lichen planus
12. A prospective follow-up study of 570 patients with oral lichen planus: persistence, remission, and malignant association
13. Oral lichen planus and squamous carcinoma
14. Relation of stress and anxiety to oral lichen planus
15. Childhood lichen planus— a question of therapy
16. The seasonal incidence of lichen planus
17. The variations and course of lichen planus
18. Unilateral lichen planus: an unusual presentation
19. Unilateral lichen p;anus
20. Lichen planus
21. Lichen planus: review and update on pathogenesis
22. The oesophagus in lichen planus: an endoscopic study
23. Systemic isotretinoin treatment of oral and cutaneous lichen planus
24. Oral lichen planus
25. The association of mucocutaneous lichen planus and chronic liver disease
26. Oral lichen planus. 1. A clinical evaluation of 115 cases
27. Unusual variations of lichen planus
28. A histologic study of epithelial dysplasia in oral lichen planus
29. Malignant potential of oral lichen planus: observation in 722 patients from India
30. Lichen planus evoked by periodontal surgery
31. Lichen planus pemphigoides with extensive melanosis
32. Desquamative vaginitis: lichen planus in disguise
33. Lichen planus of the vulva
34. The vulvo-vaginal-gingival syndrome: a new form of erosive lichen planus
35. Ungual lichen planus
36. The nail in lichen planus
37. Isolated nail dystrophy due to lichen planus
38. Twenty-nail dystrophy: a variant of lichen planus
39. Twenty-nail dystrophy of childhood: a sign of localized lichen planus
40. Twenty-nail dystrophy of childhood
41. Lichen planus atrophicus annularis
42. Summertime actinic lichenoid eruption (lichen planus actinicus)
43. Actinic lichen planus: a clinicopathologic study of 16 patients
44. Lichen planus subtropicus
45. Lichen planus tropicus
46. Lichen planus actinicus (lichen planes in subtropical countries)
47. Actinic lichen planes mimicking melasma
48. Familial lichen planus
49. Lichen planus pemphigoides-like lesions induced by cinnarizine
50. Lichen planus pemphigoides
51. Positive Nikolsky's and bulla-spread signs in acute bullous lichen planes
52. Lichenoid drug reactions to chlorpropamide and tolazamide
53. Drug-induced bullous lichen planus in a patient with diabetes mellitus and liver disease
54. Lichen planus pemphigoides: clinical and immunofluorescent findings in four cases
55. Lichen planus pemphigoides: case report and results of immunofluorescence and immunoelectron microscopic study
56. Lichen planes pemphigoides: entity or association?
57. Bullous lichen planes: diagnosis by indirect immunofluorescence and treatment with dapsone
58. Coexistence of lichen planus and bullous pemphigoid
59. Lichen planus and bullous pemphigoid
60. Captopril-induced lichen planus pemphigoides with pemphggus-like features
61. Lichen planus pemphigoides; report of a case with oral lesions
62. Pseudopelade of Brocq secondary to lichen planus
63. Ashy dermatosis—a variant of lichen planus?
64. Vitamin A in the treatment of lichen planus pigmentosus
65. An unusual variant of lupus erythematosus or lichen planus
66. Perforating lichen planus
67. Pruritic zosteriform eruption
68. Familial lichen planus
69. Familial lichen planus
70. Ultrastructural observations on lichen planus
71. The role of the epidermis in the histopathogenesis of lichen planus
72. T cell subsets and Langerhans cells in lichen planus: in situ characterization using monoclonal antibodies
73. Lichen planus: evaluation of cells in skin lesions and of T-ymphocyte subsets in blood
74. Immunohistochemical analysis of cells in mucosal lesions of oral lichen planus
75. Lichen planus, Wickham's striae and blood vessels
76. Who was Wickham and what are his striae?
77. An immunofluorescence study of lichen planus
78. Ultrastructure of the dermo-epidermal junction in lichen planes
79. Histopathology of lichen planus based on analysis of one hundred biopsy specimens
80. Current concepts in lichen planus
81. Ultrastructural localization of immunoglobulin and fibrin in lichen planus
82. Immunopathology of oral mucosal inflammatory diseases
83. Electron microscopy of intranuclear particles in lichen ruber planus
84. Lichen planopilaris
85. Lichen planus pigmentosus
86. Lichenoid secondary syphilis
87. Coexistence of lichen planus and systemic lupus erythematosus
88. Lichenoid dermatitis: a clinicopathologic and immunpathologic review of sixty-two cases
89. The isomorphic response to Koebner
90. Lichen planus with squamous carcinoma
91. Keratoacanthomas arising in hypertrophie lichen planus
92. Transformation of oral lichen planus to squamous cell carcinoma: a literature review and report of case
93. Malignant development of lichen planus-affected oral mucosa
94. Erythroplakic lesions in relation to oral lichen planus
95. Late sequelae of atabrine dermatitis—a new pre-malignant entity
96. Yeast species and biotypes associated with oral leukoplakia and lichen planus
97. Malignant degeneration of lichen planus
98. Lichen ruber and sympathicoblastoma
99. Lichen ruber bullosus and tumours in internal organs
100. Lichen ruber pemphigoides: manifestation para-neoplasique?
101. Erosive lichen planus and fibroxanthosarcoma (malignant fibrohistiocytoma): coincidence or association
102. Thymoma, acquired hypogammaglobulinaemia, lichen planus, alopecia areata
103. Triad of lichen planus, myasthenia gravis, and thymoma
104. Lichen planus in two immunodeficient hosts
105. Lichen planus, chronic liver diseases, and immunologic involvement
106. Liver abnormalities in patients with lichen planus
107. Lichen planus and the liver
108. Oral erosive lichen planus and chronic liver disease
109. Lichen-hepatitis syndrome
110. Lichen planus and primary biliary cirrhosis
111. Primary biliary cirrhosis and lichen planus
112. Lichenoid eruption following penicillamine
113. Chronic active hepatitis and lichen planus
114. Lichen planus and chronic active hepatitis
115. Lichen planus following HBV vaccination: a coincidence?
116. Myasthenia gravis, ulcerative colitis and lichen planus
117. Ulcerative colitis, myasthenia gravis, atypical lichen planus, alopecia areata, vitiligo
118. Lichen planus and ulcerative colitis
119. Lichen planus and ulcerative colitis
120. Lichen planus and its association with diabetes mellitus
121. Glucose tolerance in lichen planus
122. Carbohydrate metabolism in lichen planus
123. Glucose tolerance in patients with oral lichen planus
124. Glucose tolerance in patients with lesions of the oral mucosa
125. Incidence of diabetes mellitus in patients with oral lichen planus
126. Assessment of plasma glucose in 99 patients with oral lichen planes
127. Glucose tolerance studies in lichen planus
128. Summary of the Bedford diabetic survey
129. HLA system in relation to carbohydrate metabolism in lichen planus
130. Coincidence of vitiligo, alopecia areata, onychodystrophy, localized scleroderrria and lichen planus
131. Lichen planus with late onset hypogammaglobulinaemia: a causal relationship?
132. The autoimmune background in lichen planus
133. Duhring-Brocq disease followed by or associated with lichen planus
134. Ulcerative lichen planus with associated sicca syndrome and good therapeutic result of skin grafting
135. Pemphigus vulgaris and pemphigus foliaceus coexisting with oral lichen planus
136. Lichen planus pemphigoides with features of lichen planus and pemphigus vulgaris
137. An apparent association of lichen planus with vascular hypertension
138. Lichen planus and its possible association with vascular hypertension
139. Arterial blood pressure in patients with oral lichen planus
140. Urolithiasis in lichen planus
141. Haematological abnormalities in oral lichen planus, candidiasis, leukoplakia and non-specific stomatitis
142. Bone marrow investigation in patients with lichen planus
143. Erythrocyte glucose-6-phosphate dehydrogenase in lichen planus
144. ABO blood groups in lichen planus
145. Lichen planus and discoid lupus erythematosus
146. Unusual variant of lupus erythematosus or lichen planus
147. Mixed lichen planus-lupus erythematosus disease
148. A histochemical approach to the differentiation of lichen planus from lupus erythematosus
149. Lichenoid eruption produced by captopil
150. Angiotensin-converting enzyme inhibitors implicated in oral mucosal lichenoid reactions
151. Lichenoid drug eruptions
152. Bullous lichen planus caused by labetalol
153. Lichenoid drug reaction from methyldopa
154. Ulcerative lichenoid eruption from methyldopa
155. Lichenoid eruptions due to methyldopa
156. Cutaneous and ocular reaction to practolol
157. Skin reactions associated with propranolol
158. Lichenoid drug eruption induced by propranolol
159. Spironolaetone-induced lichen planus
160. Photosensitive lichenoid eruption associated with demeclocycline
161. Photosensitive lichenoid eruption associated with demeclocychne
162. Ethambutol-induced lichenoid eruption
163. Treatment of lichen planus with griseofulvin
164. Lichenoid lesions of oral mucosa associated with ketoconazole
165. Levamisole-induced lichenoid eruptions
166. Lichen planus-like drug eruption due to para-amino salicylic acid
167. Quatre cas de lichen plan au cours de traîtment par streptomycine, PAS et INH
168. Lichen planus-like drug eruption
169. Naproxen-induced lichen planus
170. Non-steroidal anti-inflammatory drugs and oral lichenoid reactions
171. Acetylsalicylic acid may induce a lichenoid eruption
172. Lichenoid dermatitis due to chloroquine
173. Clinical observations on atypical lichen planus and related dermatoses presumably due to atabrine toxicity
174. Quinacrine hydrochloride drug eruption (tropical lichenoid dermatitis)
175. Lichen planus following quinidine therapy
176. Lichenoid quinidine eruption
177. Quinidine-induced lichen planus
178. Quinine lichenoid photosensitivity
179. Photosensitive lichenoid reaction accompanied by nonphotosensitive sub-acute prurigo caused by carbamazepine
180. Lichenoid dermatitis resulting from treatment with the phenothiazine derivatives metopromazine and laevomepromazine
181. Ativan (lorazepam) induced lichenoid reaction of the human attached gingiva: case report
182. Lichen planus-like eruption caused by color developer
183. Lichen planus in relation to occupational and non-occupational exposure to chemicals
184. Occupational dermatitis from IPPD in tires
185. Lichenoid eruption due to chlorpropamide
186. Lichen planus, (?) tolbutamide drug eruption
187. Allopurinol-amplified lichenoid reactions of the oral mucosa
188. Lichenoid eruption due to amphenazole
189. Portacion al estudio del estudio del liquen piano arsenical
190. Immunofluorescence study of drug-induced lichen planus-like lesions
191. Gold dermatitis: a clinical and histopathological study
192. Lichenoid eruption due to mercaptopropionlyglycine
193. Lichenoid photocontact dermatitis to musk ambrette
194. Penicillamine-induced skin lesions
195. Lichen planus caused by pyrimethamine
196. Bullous lichen planus after intravenous pyelography
197. Lichenoid eruptions following contact dermatitis
198. Clinical investigation of a new cutaneous entity
199. Lichenoid dermatitis caused by nickel salts?
200. Lichenoid contact dermatitis due to aminoglycoside antibiotics
201. Skin disease from colour developers
202. Lichen planus and liver disease
203. Ueber eine neue knötchtenförmige Hauteruption: lichen nitidus
204. Lichen nitidus associated with distinctive nail changes
205. Lichen nitidus
206. Lichen nitidus associated with nail changes
207. Lichen nitidus: electron microscopic and immunofluorescence studies
208. Perforating lichen nitidus
209. Treatment of generalized lichen nitidus with PUVA
210. Generalized lichen nitidus: report of two cases treated with astemizol
211. Keratosis lichenoides chronica
212. Sur la question du lichen moniliforme
213. Keratosis lichenoides chronica
214. Keratosis lichenodes chronica: possible variant of lichen planus
215. Keratosis lichenoides chronica is synonymous with lichen planus
216. Keratosis lichenoides chronica
217. Graft versus host reaction and lichen planus
218. Graft versus host reaction and lichen planus-like eruption in man
219. Lichen-planus-like eruption following bone marrow transplantation: a manifestation of the graft-versus-host disease
220. Acral erythemas induced by chemotherapy and graft-versus-host disease in adults with hematogenous malignancies
221. Graft vs host reaction in a newborn
222. Transfusion-associated graft-vs-host disease in patients with malignancies
223. Post-transfusion graft-versus-host disease after open-heart surgery
224. Graft-versus-host disease
225. Cutaneous graft versus host disease
226. Blood transfusions and graft-vs-host disease
227. Deposition of IgM and complement at the dermoepidermal junction in acute and chronic cutaneous graft-versus-host disease in man
228. Skin antibodies in bone marrow transplanted patients
229. Cyclosporin A for the treatment of graft-versus-host disease in man
230. Dermatological aspects of the use of cyclosporin A for prophylaxis of graft versus host disease
231. Lichen planus dermopathy: demonstration of a lichen planus specific epidermal antigen in affected patients
232. Indirect immunofluorescence microscopy of lichen planus
233. Indirect immunofluorescence of oral lichen planus
234. Childhood bullous lichen planus
235. Deposits of immunoglobulins, complement, and fibrinogen in oral lupus erythematosus, lichen planus, and leukoplakia
236. T-cell infiltrate in lichen planus. Demonstration of activated lymphocytes using monoclonal antibodies
237. Oral lichen planus: an immunoperoxidase study using monoclonal antibodies to lymphocyte subsets
238. Immunohistochemical demonstration of T cell subsets and accessory cells in oral lichen planus
239. Lesional keratinocytes express OKM5, Leu-8 and Leu-IIb antigens in lichen planus
240. Expression of MHC class II antigens (HLA DR, DP and DQ) by keratinocytes in oral lichen planus
241. Glucose-6-phosphate dehydrogenase in lichen planus skin
242. β-Hydroxyacyl-CoA dehydrogenase and glucose-6-phosphate dehydrogenase in normal human skin and in some papulosquamous diseases of the skin
243. Lichen planus; an inborn error of metabolism
244. Histochemical studies on lichen planus
245. Changes in carbohydrate expression of lichen planus affected oral epithelial cell membranes
246. Lichenoid dermatitis
247. The lichenoid tissue reaction
248. The lichenoid tissue reaction
249. The lichenoid tissue reaction
250. Serum immunoglobulins in Nigerian patients with lichen planus
251. Deficiency of circulating IgA and IgM in adult patients with lichen planus
252. Serum immunoglobulins and complement (C′3) in oral lichen planus
253. Serum IgG, IgA, IgM, IgD and IgE in lichen planus: no evidence for a humoral immunodeficiency
254. Serum immunoglobulins in lichen planus
255. The pathogenesis of lichen planus
256. Etiology of lichen planus
257. Subsets of T lymphocytes in peripheral blood of patients with oral lichen planus
258. Hypertrophic lichen planus and light sensitivity in an HIV-positive patient
259. 2 microglobulin in lichen planus
260. Basic and interleukin-2-augmented natural killer cell activity in lichen planus
261. Circulating immune complex studies on patients with oral lichen planus
262. HL-A antigens in lichen planus
263. HLA antigens associated with lichen planus
264. An association between HLA DR1 and lichen planus
265. HLA-DR and DQ antigens in lichen planus
266. HLA markers and lymphocytotoxins in lichen planus
267. Lichen planus in monozygotic twins
268. Familial lichen planus
269. Occurrence of lichen planus in a family
270. Psychiatric disturbance in patients with oral lichen planus
271. Oral lichen planus according to the modern medical model
272. Electron-microscopic demonstration of bacteria in the skin o£ patients with lichen ruber planus
273. Intestinal amebiasis, lichen planus, and treatment with metronidazole
274. Lichen planus: failure to cultivate viruses or mycoplasma
275. Candida in patients with oral lichen planus
276. Donor toxicity in granulocyte collections: association of lichen planus with the use of hydroxyethyl starch leukapheresis
277. Bullous lichen planus developed on erythema ab igne
278. Intermittent megadose corticosteroid therapy for generalized lichen planus
279. Betamethasone valerate aerosol in the treatment of oral lichen planus
280. The surgical treatment of oral lichen planus
281. Retinoic acid in the treatment of lichen planus
282. Topical tretinoin therapy and oral lichen planus
283. Topical application of isotretinoin gel improves oral lichen planus
284. Severe oral lichen planus: treatment with an aromatic retinoid (etretinate)
285. The treatment of erosive lichen planus with a retinoid—etretinate
286. Treatment of lichen planus with temarotene
287. Use of griseofulvin
288. Histopathological evaluation of griseofulvin therapy in lichen planus
289. Treatment of lichen planus with griseofulvin
290. Griseofulvin in the treatment of three cases of oral erosive lichen planus
291. Griseofulvin therapy of lichen planus
292. Oral photochemotherapy in the treatment of lichen planus (LP)
293. Bilateral comparison of generalized lichen planus treated with psoralens and ultraviolet A
294. A newly developed method for treatment of oral lichen planus with ultraviolet irradiation
295. Surgical treatment of lichen planus of the soles
296. Plantar lichen planus— treatment by excision and skin grafting
297. Surgical treatment of painful lichen planus of the hand and food
298. Cryosurgical treatment of a gingival lichen planus: report of a case
299. Use of the carbon dioxide laser in the management of premalignant lesions of the oral mucosa
300. Treatment of severe lichen planus with cyclosporine
301. Cyclosporin A in the treatment of lichen planus
302. Effect of topical cyclosporine rinse on oral lichen planus
303. Cyclosporine in dermatology
304. Lichen planus treated with levamisole
305. Treatment of lichen planus with bactrim
306. Aureomycin treatment of some dermatoses
307. Dapsone in the treatment of erosive lichen planus
308. Treatment of erosive lichen planus with dapsone
309. Sustained remission of generalized lichen planus induced by cyclophosphamide
310. Lichen planus in subtropical countries
311. Lichen planus actinicus
312. Lichen planus of the nail; treatment with antimalarials
313. Lichen planus; treatment of thirty cases with systemic and topical phenytoin
314. Vitamin status of patients with oral lichen planus
315. Follow-up studies in oral lichen planus
316. Studies on oral lichen planus. II. Follow-up on 200 patients, clinical characteristics, and associated malignancy
317. Studies on oral lichen planus. III. Clinical and histologic correlations in 213 patients